Table 1 Demographic characteristics of participants across different tertiles of MIND score.

From: Association between adherence to Mediterranean-DASH intervention for neurodegenerative delay diet and disease severity in patients with ulcerative colitis

Variables

MIND score

Tertile 1

(n = 52)

Tertile 2 (n = 57)

Tertile 3 (n = 49)

p-value

Demographic information

Age (years) mean ± SD

41.23 ± 13.79

43.49 ± 12.61

42.76 ± 11.39

0.64*

Sex (male) n(%)

27 (51.9)

28 (49.1)

29 (59.2)

0.57**

Current smoker n(%)

8 (15.4)

7 (12.3)

7 (14.3)

0.89**

Disease-related information

Disease duration (Month) mean ± SD

8.12 ± 3.36

7.88 ± 5.22

7.78 ± 6.09

0.92*

Treatments

Mezalazine n(%)

52 (100)

53(100)

53 (100)

-

Azathioprine n(%)

38 (73.1)

39 (68.4)

31 (63.3)

0.57**

Prednisolone n(%)

27 (51.9)

21 (36.8)

11 (22.4)

0.02**

Disease extension n(%)

Ulcerative proctitis

3 (5.8)

8 (14)

5 (10.2)

0.18**

Left-sided colitis

23 (44.2)

33 (57.9)

31 (63.3)

Proctosigmoiditis

21 (40.4)

13 (22.8)

11 (22.4)

Pancolitis

5 (9.6)

3 (5.3)

2 (4.1)

Nutrition-related information

    

Energy intake (kcal/day) mean ± SD

2203.47 ± 332.63

2154.68 ± 361.99

2149.89 ± 455.26

0.73

Carbohydrate (g/day)

345.70 ± 72.84

331.44 ± 11.45

331.92 ± 78.43

0.52

Protein (g/day)

66.20 ± 12.89

64.88 ± 12.13

66.72 ± 15.50

0.76

Fat (g/day)

65.40 ± 11.23

67.58 ± 11.45

65.73 ± 16.20

0.64

BMI (Kg/m2) mean ± SD

24.97 ± 3.58

26.79 ± 5.48

25.55 ± 3.35

0.08*

BMI categories n(%)

    

<18.5 (Kg/m 2 )

1 (1.9)

2 (3.5)

2 (4.1)

0.73**

18.5–24.99 (Kg/m 2 )

26 (50.0)

25 (43.9)

18 (36.7)

≥25 (Kg/m 2 )

25 (48.1)

30 (52.6)

29 (59.2)

Nutritional supplements use n(%)

46 (88.5)

49 (86)

43 (87.8)

0.92**

Following diet n(%)

11 (21.2)

18 (31.6)

26 (53.1)

0.009*

  1. BMI: body mass index; MIND: Mediterranean-DASH Intervention for Neurodegenerative Delay.
  2. *p-value of one-way ANOVA.
  3. **p-value of chi-square.